Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 7Colorectal Neoplasms 4Breast Neoplasms 4Small Cell Lung Carcinoma 3Neoplasms 3Lung Neoplasms 3Stomatitis 2Male Urogenital Diseases 2Cardiovascular Diseases 2Carcinoma, Non-Small-Cell Lung 2Vascular Diseases 1Ulcer 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Radiation-induced Injuries in Patients With Rectal Cancer 1Radiation Injuries 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Non-melanoma Skin Cancer 1Neurotoxicity Syndromes 1Myocardial Ischemia 1Myocardial Infarction 1Lymphoma, Follicular 1Heart Diseases 1Head and Neck Neoplasms 1Fibrosis 1Fatigue 1Eye Diseases 1Erectile Dysfunction 1Dyspareunia 1

Interventions

padeliporfin 5Lycopene 3Vitamin E 2Tea 2Selenium 2Cholecalciferol 2relatlimab 1pembrolizumab 1palladium-bacteriopheophorbide 1Therapeutics 1Surveys and Questionnaires 1Sugars 1Nivolumab 1Intraoperative Neurophysiological Monitoring 1CP protocol 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Male Urogenital Diseases × Vitamin E × Clear all
NCT00744549 2018-02-14

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

University Health Network, Toronto

Phase 2 Completed
16 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

NCT00844792 2017-10-26

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
48 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡